CTEV — Claritev Corporation stock price, charts and financials

QT43Claritev Corporation

Claritev Corporation (NYSE: CTEV) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
26.40
+2.11+8.69%
CTEVQT43Claritev Corporation·NYSE
26.40+8.69%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E-EPS (ttm)-17.33Insider Own23.65%Shs Outstand17.05MPerf Week11.32%
Market Cap414.09MForward P/E-EPS next Y-13.87Insider Trans2.41%Shs Float7.28MPerf Month-25.58%
Enterprise Value5.00BPEG-EPS next Q-Inst Own-Short Float5.79%Perf Quarter-2.57%
Income-288.00MP/S0.42EPS this Y8.09%Inst Trans-Short Ratio6.74Perf Half Y-10.57%
Sales980.00MP/B-EPS next Y12.89%ROA-5.92%Short Interest986.97KPerf YTD-43.18%
Book/sh-13.73P/C19.72EPS next 5Y-ROE205.84%52W High80.51 -67.21%Perf Year-39.08%
Cash/sh1.23P/FCF-EPS past 3/5Y-ROIC0.78%52W Low12.50 111.22%Perf 3Y-
Dividend Est.-EV/EBITDA9.66Sales past 3/5Y-3.68% 0.57%Gross Margin61.06%Volatility8.59% 8.77%Perf 5Y-
Dividend TTM-EV/Sales5.10EPS Y/Y TTM83.00%Oper. Margin4.29%ATR (14)2.42Perf 10Y-
Dividend Ex-Date-Quick Ratio1.28Sales Y/Y TTM5.26%Profit Margin-29.27%RSI (14)41.95Recom2.17
Dividend Gr. 3/5Y-Current Ratio1.28EPS Q/Q-28.57%SMA20-10.65%Beta2.18Target Price38.80
Payout0.00%Debt/Eq54.01Sales Q/Q6.06%SMA50-13.86%Rel Volume0.38Prev Close24.29
Employees3,000LT Debt/Eq-27.62EarningsAug 07SMA200-22.32%Avg Volume149.12KPrice26.40
IPO DateApr 03, 2020Option/ShortYes / YesEPS/Sales Surpr.-7.94% 3.51%Net Debt/EBITDA8.87Volume55,917Change8.69%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-21-26ReiteratedCanaccord GenuityBuy$37
Jun-03-26ReiteratedPiper SandlerOverweight$90$61
Apr-24-26InitiatedBarclaysOverweight$28
Feb-24-26ReiteratedGuggenheimBuy$38
Feb-24-26ReiteratedWells FargoEqual Weight$33$30
Jan-08-26InitiatedWells FargoEqual Weight$33
Oct-22-25UpgradeCitigroupNeutralBuy
Oct-21-25UpgradeCitigroupNeutralBuy
May-29-25UpgradePiper SandlerNeutralOverweight
Latest News
Aug-04-26
Jul-30-26
Jul-28-26
Jul-21-26
Jul-16-26
Jul-14-26
Jul-09-26
Jun-22-26
Jun-17-26
Company

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue9809659319621,0801,1189389831,041
Cost of Goods Sold Incl. D&A381699239235204175319150149
Gross Profit599267691726876942619833891
Selling, General and Administrative Excl. Other2072221601361321513567578
Research and Development
000000000
Other Operating Expense34901,9214281,106405395390386
Operating Income4345-1,390162-363386-132368428
Interest Expense398400326333303267336376383
Unusual Expense
Non-Operating Income (Expense)27-18-546410517-79190
Net Income Before Taxes-329-373-1,771-107-561135-5471144
Income Taxes-41-89-125-151233-2618
Consolidated Net Income-288-284-1,646-92-573102-5211036
Net Income From Continuing Operations-288-284-1,646-92-573102-5211036
Net Income-288-284-1,646-92-573102-5211036
EPS (Recurring)-17.33-17.30-101.92-5.69-35.876.40-44.230.351.32
EPS (Basic, Before Extraordinaries)-17.33-17.30-101.92-5.69-35.876.40-44.230.351.32
EPS (Diluted)-17.33-17.30-101.92-5.69-35.876.40-44.230.351.32
EBITDA518475-1,008652158815192786814
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio
Price To Sales Ratio0.460.71
Gross Margin61.1227.6774.2275.4781.1184.2665.9984.7485.59
Operating Margin4.394.66-149.3016.84-33.6134.53-14.0737.4441.11
Net Margin-29.39-29.43-176.80-9.56-53.069.12-55.541.023.46
Shares Outstanding171616161616122828
Market Capitalization449684
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$81.45$62.24$43.02$23.81$4.60 Close Price0.00M18.25M36.50M54.75M73.00MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Carol NutterSVP, Chief People OfficerJun 09 '26Buy28.4187524,85646,941Jun 10
Prince John MichaelDirectorMay 19 '26Buy16.0010,000160,00031,662May 19
Dalton TravisPres., CEO & Executive ChairMay 18 '26Buy12.3620,920258,63845,872May 19
Kim MichaelEVP, Chief Digital OfficerMay 18 '26Buy16.653,00049,950185,878May 19
Garis Douglas MichaelEVP&CFOMar 16 '26Buy17.691,30022,997206,152Mar 16
Kim MichaelEVP, Chief Digital OfficerMar 12 '26Buy16.5015,000247,500182,878Mar 16
O'Neil TaraSVP, General CounselMar 02 '26Buy12.997509,74327,199Mar 02
Dalton TravisPres., CEO & Executive ChairFeb 27 '26Buy13.0015,380199,92824,952Mar 02
Kim MichaelEVP, Chief Digital OfficerFeb 27 '26Buy14.3030,000428,955137,973Mar 02
Dalton TravisPres., CEO & Executive ChairNov 20 '25Buy47.235,290249,8429,572Nov 20
Mintz William B.SVP, Chief Strategy OfficerNov 17 '25Buy38.0091634,80865,325Nov 19
Kim MichaelEVP, Chief Digital OfficerNov 17 '25Buy38.259,600367,199105,529Nov 18
O'Neil TaraSVP, General CounselNov 17 '25Buy38.8462524,27325,028Nov 18
H&F Corporate Investors VIII, Ltd.10% OwnerNov 12 '25Sale48.671,500,00073,001,2498,932Nov 14
Dalton TravisPres., CEO & Executive ChairAug 11 '25Buy58.303,982232,1584,282Aug 12
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.